Brain-specific TRAF7 deletion ameliorates traumatic brain injury by suppressing MEKK3-regulated glial inflammation and neuronal death

Int Immunopharmacol. 2022 Feb:103:108219. doi: 10.1016/j.intimp.2021.108219. Epub 2021 Dec 23.

Abstract

Neuronal death and neuroinflammation play critical roles in regulating the progression of traumatic brain injury (TBI). However, associated pathogenesis has not been fully understood. Tumor necrosis factor receptor-associated factor 7 (TRAF7), as the unique noncanonical member of the TRAF family, mediates various essential biological processes. Nevertheless, the effects of TRAF7 on TBI are still unclear. In this study, we showed that TRAF7 expression was markedly up-regulated in cortex and hippocampus of mice after TBI. Brain-specific TRAF7 deletion markedly ameliorated neuronal death in cortical and hippocampal samples of TBI mice, accompanied with cognitive impairments and motor dysfunction. Moreover, the aberrant activation of astrocyte and microglia in cortex and hippocampus of TBI mice was significantly restrained by TRAF7 conditional knockout in brain, as indicated by the increased expression of GFAP and Iba1. In addition, the releases of pro-inflammatory factors caused by TBI were also considerably diminished by brain-specific TRAF7 knockout, which were largely through the blockage of nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) signaling pathways. Importantly, mitogen-activated protein kinase kinase kinase 3 (MEKK3) expression levels were greatly enhanced in cortex and hippocampus of mice with TBI, while being dramatically ameliorated by TRAF7 knockout in brain. Mechanistically, we showed that TRAF7 directly interacted with MEKK3. Of note, MEKK3 over-expression almost abrogated the capacity of TRAF7 knockout to mitigate neuronal death and neuroinflammation in the isolated primary cortical neurons and glial cells upon oxygen-glucose-deprivation/reperfusion (OGD/R) stimulation. Collectively, TRAF7 may be an important molecular switch that leads to TBI in a MEKK3-dependent manner, and can be served as a therapeutic target for TBI treatment.

Keywords: MEKK3; Neuroinflammation; Neuronal death; TRAF7; Traumatic brain injury (TBI).

MeSH terms

  • Animals
  • Apoptosis
  • Brain / physiology*
  • Brain Injuries, Traumatic / immunology*
  • Cells, Cultured
  • Humans
  • Immunosuppression Therapy
  • MAP Kinase Kinase Kinase 3 / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neurogenic Inflammation
  • Neuroglia / physiology*
  • Neurons / physiology*
  • Organ Specificity
  • Sequence Deletion
  • Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / genetics
  • Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / metabolism*

Substances

  • Traf7 protein, mouse
  • Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
  • MAP Kinase Kinase Kinase 3